References
- Orwoll E. S., Klein R. F. Osteoporosis in men. Endocr Rev 1995; 16: 298–327
- Kudlacek S., Schneider B., Freudenthaler O., Willvonseder R. Differences in bone mineral density and fracture risk between women and men. J Bone Miner Res 1998; 23(Suppl 5)314
- Melton L. J. I. I. I. Epidemiology of spinal osteoporosis. Spine 1997; 22: 2–11
- Francis R., Klibanski A., Neer R. Osteoporosis in hypogonadal men: role of decreased plasma 1,25‐OH2 vitamin D, calcium malabsorption and low bone formation. Bone 1986; 7: 261–8
- Stepan J., Lachmann M., Zverina J., Pacovsky V., Baylink D. Castrated men exhibited bone loss. Effect of calcitonin treatment on biochemical indices of bone remodelling. J Clin Endocrinol Metab 1989; 69: 523–7
- Kasparek Ch, Wgedal J., Farley J. Androgens directly stimulate proliferation of bone cells. in vitro. Endocrinology 1989; 124: 1576–8
- Mosekilde L. Sex differences in age related bone loss of vertebral trabecular bone mass and structure ‐ biomechanical consequences. Bone 1989; 10: 425–32
- Poor G., Atkinson E., Lewallen D., O'Fallon W., Melton L. I. I. I. Age related hip fractures in men: clinical spectrum and short term outcomes. Osteoporos Int 1996; 6: 233–9
- Seeman E. Osteoporosis in men. Osteoporos Int 1999; 2(Suppl 2)S97–110
- Resch A., Schneider B., Bernecker P., Battman A., Wergedal J., Willvonseder R., Resch H. Risk of vertebral fractures in men: relationship to mineral bone density of the vertebral body. Am J Roentgenol 1995; 164: 1447–50
- Stewart A., Felsenberg D., Kalidis L., Reid D. Vertebral fractures in men and women: how discriminative are bone mass measurements?. Br J Radiol 1995; 68: 614–20
- Agnusdei D., Gerardi D., Camporela A., Martini G., Gennari C. The European vertebral osteoporosis study in Siena, Italy. Bone 1994; 16(Suppl 1)118S
- Santavirta S., Kottinen Y., Heliovaara M., Knekt P., Luthje P., Aromaa A. Determinants of osteoporotic thoracic vertebral fracture. Screening of 57 000 Finnish women and men. Acta Orthop Scand 1992; 63: 198–202
- Bagatell C., Bremner W. Androgens in men ‐ use and abuse. N Engl J Med 1996; 334: 707–13
- Gray A., Feldman H. A., McKinley J. B., Longcope C. Age, disease and changing sex hormone levels in middle‐aged men. Results of the Massachusetts Male Aging study. J Clin Endocrinol Metab 1991; 72: 1016–25
- Ringe J. D., Dorst A. J., Faber H. Osteoporosis in men ‐ clinical assessment of 400 patients and 205 controls by risk factor analysis, densitometry and X‐ray findings. Osteologie 1997; 6: 81–6
- Anderson F., Francis R., Peatson R., Wastell H. Androgen supplementation in eugonadal men with osteoporosis: effects of six months treatment on markers of bone formation and resorption. J Bone Miner Res 1997; 12: 472–8
- Hermann F., Behre M., Kliesch S., Leifke E., Link T., Nieschlag E. Long‐term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 2386–90
- Bernecker P., Willvonseder R., Resch H. Decreased estrogen levels in patients with primary osteoporosis. J Bone Miner Res 1995; 10(Suppl 1)T364
- Kaps P., Girg F., Stracke H. Osteoporosis in men, the predominant role of estrogen and its relation to bone mineral density. J Bone Miner Res 1998; 23(Suppl 5)S302
- Slemenda C., Langcpope C., Hui S., Zhou L., Jhonston C. Estrogens but not androgens are positively associated with bone mass in older men. Osteoporosis Int 1996; 6(Suppl 1)279
- Krexner E., Resch H., Pietschmann P., Woloszczuk W., Vukovich T., Geyer G., et al. Vitamin D status in residents of a long‐term care geriatric hospital in Vienna. Osteologie 1996; 5: 13–18
- Scharla S., Wolf S., Düll R., Lempert U. Osteopenie und andere Risikofaktoren bei Patienten mit proximaler Femurfraktue: Hinweise auf unter‐schiedliche Frakturschwelle bei Männern und Frauen. Osteologie 1997; 6(Suppl 1)94
- van der Widen R., Löwik M., van der Berg H., de Groot L., Haller J., Moreiras O., et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995; 346: 207–10
- Boonen S., Vanderschueren D., Guang Cheng X., Verbeke G., Dequeker J., Geusens P., et al. Age‐related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovkaminosis D ‐ and androgen deficiency ‐ induced bone resorption. J Bone Miner Res 1997; 12: 2119–26
- Resch H., Pietschmann P., Woloszczuk W., Krexner E., Bernecker P., Willvonseder R. Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest 1992; 22: 542–5
- Krall E., Dawson‐Hughes B., Hirst K., Gallagher J., Shermann S., Dalsky G. Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women. J Gerontol Ser Biol Sci Med Sci 1997; 52: 61–7
- Resch H., Pietschmann P., Kudlacek S., Woloszczuk W., Krexner E., Bernecker P., et al. Influence of sex and age on biochemical bone metabolism parameters. Miner Electrolyte Metab 1994; 20: 117–21
- Anderson F., Francis R., Bishop J. Effect of intermittent disodium etidronate therapy on bone mineral density in men with vertebral fractures. Age Aging 1997; 26: 359–65
- Orwoll E., Ettinger E., Weiss S., Miller P., Kendler D., Graham J., et al. Alendronate treatment in osteoporosis in men. J Bone Miner Res 1999; 14(Suppl 1)S184